derleme 10. Miravitlles M, Calle M, Soler-Cataluña JJ. Clinical phenotypes of COPD: identification, definition and implications for guidelines. Arch Bronconeumol. <strong>2012</strong>, Cilt 48, 3, s. 86-98. 11. Travers J, Laveneziana P, O’Donnell DE. Physiologic assessment of COPD. [dü.] Sharafkhaneh A. Hanania NA. COPD: A Guide to Diagnosis and Clinical Management. Respiratory Medicine. 2011, s. 33-57. 12. O’Donnell DE, Revill SM, Webb KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001, Cilt 164, 5, s. 770-777. 13. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med. 2003, Cilt 167, 4, s. 544-549. 14. Pinto-Plata VM, Cote C, Cabral H, Taylor J, Celli BR. The 6-min walk distance; change over time and value as a pre¬dictor of survival in severe COPD. Eur Respir J. 2004, Cilt 23, s. 28-33. 15. Wright JL, Levy RD, Churg A. Pulmonary hypertension in chronic obstructive pulmonary disease: Current theories of pathogenesis and their implications for treatment. Thorax. 2005, Cilt 60, s. 605-609. 16. Polatli M, Cakir A, Cildag O, Bolaman AZ, Yenisey C, Yenicerioglu Y. Microalbuminuria, von Willebrand factor and fibrinogen levels as markers of the severity in COPD exacerbation. J Thromb Thrombolysis. 2008, Cilt 26, 2, s. 97-102. 17. Polatlı, Mehmet. Kronik Obstrüktif Akciğer Hastalığında İzlem Kriterleri. [dü.] Sema Umut ve Ertürk Erdinç. Tanımdan Tedaviye Kronik Obstrüktif Akciğer Hastalığı Toraks Kitapları. s.l. : Galenos Yayıncılık, 2008, s. 383-398. 18. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002, Cilt 121, s. 1434-1440. 19. Hajiro T, Nishimura K, Tsukino M, et al. A comparison of the level of dyspnea vs disease severity in indicating the health related quality of life of patients with COPD. Chest. 1999, Cilt 116, s. 1632-1637. 20. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Oga T. Stages of disease severity and factors that affect the health statusof patients with chronic obstructive pulmonary disease. Respir Med. 2000, Cilt 94, s. 841-846. 21. Agusti AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J. 2003, Cilt 21, s. 347- 360. 22. Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet. 2007, Cilt 370, 9589, s. 797-799. 23. Chailleux E, Laaban JP, Veale D. Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy. Chest. 2003, Cilt 123, s. 1460-1466. 24. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010, Cilt 363, 12, s. 1128-1138. 25. Jennings JH, Digiovine B, Obeid D, Frank C. The association between depressive symptoms and acute exacerbations of COPD. Lung. 2009, Cilt 187, 2, s. 128- 135. 26. Dahlén I, Janson C. Anxiety and depression are related to the outcome of emergency treatment in patients with obstructive pulmonary disease. Chest. 2002, Cilt 122, 5, s. 1633-1637. 27. Han MK, Postma D, Mannino DM, Giardino ND, Buist S, Curtis JL, Martinez FJ. Gender and chronic obstructive pulmonary disease: why it matters. Am J Respir Crit Care Med. 2007, Cilt 176, 12, s. 1179-1184. 28. Türk Toraks Derneği <strong>KOAH</strong> Çalışma Grubu. Türk Toraks Derneği Kronik Obstrüktif Akciğer Hastalığı Tanı ve Tedavi Uzlaşı Raporu. 2010, Cilt 11, 1, s. 5-64. 29. Han MK, Agusti A, Calverley PM, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med. 2010, Cilt 182, 5, s. 598-604. 30. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The body-mass index, airflow obstruction, dyspnea and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004, Cilt 350, s. 1005- 1011. 31. Burgel PR, Paillasseur JL, Caillaud D, Tillie-Lablond I, Chanez P, Escamilla R, et al. Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. Eur Respir J. 2010, Cilt 36, s. 531-539. 32. Wardlaw AJ, Silverman M, Siva R, Pavord ID, Green R. Multi-dimensional phenotyping: towards a new taxonomy for airway disease. Clin Exp Allergy. 2005, Cilt 35, 10, s. 1254-1262. 33. Fujimoto K, Kitaguchi Y, Kubo K, Honda T. Clinical analysis of chronic obstructive pulmonary disease phenotypes classified using high-resolution computed tomography. Respirology. 2006, Cilt 11, s. 731-740. 34. Kitaguchi Y, Fujimoto K, Kubo K, Honda T. Characteristics of COPD phenotypes classified according to the findings of HRCT. Respir Med. 2006, Cilt 100, 10, s. 1742-1752. 35. Fishman A, Martinez F, Naunheim K, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003, Cilt 348, s. 2059. 36. Martinez FZ. Lung volume reduction surgery in COPD. http://www.uptodate.com. [Çevrimiçi] 20 April <strong>2012</strong>. 20
April 27-30, 2013 Çeşme - Izmir / TURKEY www.solunum.org.tr/ecbip2013 Abstract Submission Deadline 15 February 2013 ENDORSED BY EUROPEAN RESPIRATORY SOCIETY “The American College of Chest Physicians has approved this educational event, recognizing its importance toward advancing clinical practice and scientific efforts that promotes patient-focused care in the fields of pulmonary, critical care, and sleep medicine. All statements, recommendations, suggestions, or expressions of opinion contained herein, along with any handout material, are those of the author or speaker, and do not necessarily represent an official position of the American College of Chest Physicians.” EABIP President Felix Herth TRS President Mecit Süerdem, MD Congress Presidents Chris Bolliger, MD; Benan Caglayan, MD EABIP and Congress Secretary Semra Bilaceroglu, MD Contact Semra Bilaceroglu, MD s.bilaceroglu@gmail.com +90 (532) 661 45 22 +90 (232) 362 28 31 Organization Secreteriat: K2 Conference and Event Management Kosuyolu Mh. Ali Nazime Sk. No:45 Kosuyolu 34718 Kadikoy / Istanbul / Turkey Phone: +90 (216) 428 95 51 (pbx) • Fax: +90 (216) 428 95 91 • E-mail: ecbip2013@k2-events.com
- Page 1 and 2: KOAH BÜLTENİ ISSN: 1308-6723 SAYI
- Page 3 and 4: solunum sıkıntısı çeken hastal
- Page 5 and 6: dahale gerektiren majör depresyon
- Page 7 and 8: ten erkeklere göre daha fazla yak
- Page 9 and 10: 37. Khdour MR, Hawwa AF, Kidney JC,
- Page 11 and 12: önemli rolü vardır. Klasik olara
- Page 13 and 14: nın genel durumu, sosyal durumu, i
- Page 15 and 16: KOAH, hava akımı kısıtlılığ
- Page 17 and 18: KOAH’ta Klinik Fenotipler KOAH’
- Page 19: fizem varlığı ve tipi (sentrlob
- Page 23 and 24: ağmen, örneğin ABD’de kadınla
- Page 25 and 26: tine bakıldığında ise KOAH biri
- Page 27 and 28: Kronik Obstrüktif Akciğer Hastal
- Page 29 and 30: Sigara dumanı ve onarım Sigara du
- Page 31 and 32: Akciğer onarımı: Alveol Bir dizi
- Page 33 and 34: me yetenekleri yoktur. Ayrıca, KOA
- Page 35 and 36: ortaya çıkan kanıtlar bu alanda
- Page 37 and 38: nektin ve insülin direnci ile KOAH
- Page 39 and 40: Tablo 2: Çalışmaya alınan hasta
- Page 41 and 42: S, Gjomarkaj M, Bonsignore G, Bousq
- Page 43 and 44: hastalıklar açısından düzeltil
- Page 45 and 46: Sonuçlar Kriterlere uyan 111 hasta
Change language